Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NASC

Nascent Pharma Holdings, Inc.

USD

Set alert

Price alert · NASC

All alert types
0.01 USD -0.01 -40.00%
As of Oct 30, 2026
0.009 Day range 0.01
0.007 52-week range 0.035
YTD
-43.75%
1 year
-55.00%
Open
0.01
Prev close
0.015
Mkt cap
811.95K
Vol
90.00K
Avg vol
44.25K
EPS
0.11
P/E
0.08
More statistics
Low
0.009
High
0.01

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NASC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-110.80 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2016: -0.4×FY 2017: -0.2×FY 2018: -0.6×FY 2019: -0.1×FY 2020: -0.0×FY 2021: -0.1×FY 2022: -0.3×FY 2023: -0.0×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.2× FY 2025
P/S 0.0×
FY 2016: 3.0×FY 2017: 3.1×FY 2018: 3.5×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.7×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
P/B -0.1×
FY 2016: -0.5×FY 2017: -0.2×FY 2018: 0.7×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 1.7×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
P/FCF 0.0×
FY 2016: -2.0×FY 2017: -1.3×FY 2018: -2.9×FY 2019: -0.1×FY 2020: -0.1×FY 2021: -0.1×FY 2022: -1.2×FY 2023: -0.3×FY 2024: -9.4×FY 2025: 0.0×
FY 2016 5y median -0.3× FY 2025
EV/EBITDA -4.2×
FY 2016: -0.5×FY 2017: -0.3×FY 2018: -0.4×FY 2019: -0.1×FY 2020: -0.2×FY 2021: -0.8×FY 2022: -1.1×FY 2023: -1.6×FY 2024: -1.4×FY 2025: -4.2×
FY 2016 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2016: 3.3×FY 2017: 4.6×FY 2018: 2.3×FY 2019: 0.3×FY 2020: 1.0×FY 2021: 1.6×FY 2022: 2.1×FY 2023: 4.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 1.6× FY 2025
FCF Yield 0.0%
FY 2016: -50.6%FY 2017: -76.4%FY 2018: -34.5%FY 2019: -766.0%FY 2020: -1304.0%FY 2021: -1197.0%FY 2022: -85.1%FY 2023: -395.5%FY 2024: -10.7%FY 2025: 0.0%
FY 2016 5y median -85.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: 63.8%FY 2018: 39.3%FY 2019: 74.0%FY 2020: 83.7%FY 2021: 65.0%FY 2022: 39.1%FY 2023: 16.6%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 16.6% FY 2025
Operating Margin 0.0%
FY 2016: -432.5%FY 2017: -580.7%FY 2018: -510.9%FY 2019: -255.6%FY 2020: -440.8%FY 2021: -223.0%FY 2022: -211.9%FY 2023: -347.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -211.9% FY 2025
Net Margin 0.0%
FY 2016: -699.0%FY 2017: -1743.2%FY 2018: -615.1%FY 2019: -255.9%FY 2020: -519.3%FY 2021: -264.3%FY 2022: -223.2%FY 2023: -451.7%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -223.2% FY 2025
ROE 37.6%
FY 2016: 129.2%FY 2017: 123.7%FY 2018: -117.9%FY 2019: -92.7%FY 2020: -601.5%FY 2021: -216.6%FY 2022: -553.2%FY 2023: 971.8%FY 2024: 80.2%FY 2025: 37.6%
FY 2016 5y median 37.6% FY 2025
ROIC 59.7%
FY 2016: 90.2%FY 2017: 46.4%FY 2018: -97.4%FY 2019: -90.7%FY 2020: -211.9%FY 2021: -79.6%FY 2022: -117.7%FY 2023: -91.5%FY 2024: 107.7%FY 2025: 59.7%
FY 2016 5y median -79.6% FY 2025
ROA -7432.0%
FY 2016: -485.5%FY 2017: -975.7%FY 2018: -111.3%FY 2019: -85.1%FY 2020: -227.0%FY 2021: -73.9%FY 2022: -95.9%FY 2023: -96.2%FY 2024: -3406.4%FY 2025: -7432.0%
FY 2016 5y median -96.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -13.8%FY 2017: 29.0%FY 2018: 444.7%FY 2019: 244.8%FY 2020: -25.8%FY 2021: 169.3%FY 2022: 45.2%FY 2023: -67.8%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 48.6%
FY 2016: 73.9%FY 2017: -73.2%FY 2018: -379.2%FY 2019: -72.5%FY 2020: -27.9%FY 2021: -36.2%FY 2022: -38.0%FY 2023: 47.2%FY 2024: 36.4%FY 2025: 48.6%
FY 2016 FY 2025
EPS (diluted) 67.1%
FY 2016: 83.1%FY 2017: -195.1%FY 2018: -16.2%FY 2019: 1.5%FY 2020: 12.4%FY 2021: 76.0%FY 2022: 53.9%FY 2023: 81.6%FY 2024: 77.9%FY 2025: 67.1%
FY 2016 FY 2025
Free Cash Flow 0.0%
FY 2016: 62.4%FY 2017: -101.0%FY 2018: -179.4%FY 2019: -408.6%FY 2020: 50.9%FY 2021: -302.5%FY 2022: 50.9%FY 2023: 66.6%FY 2024: 83.2%FY 2025: 0.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 5.6×FY 2019: 6.7×FY 2020: 1.3×FY 2021: 0.7×FY 2022: 0.7×FY 2023: 0.5×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.5× FY 2025
Quick Ratio 0.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 5.2×FY 2019: 5.1×FY 2020: 1.1×FY 2021: 0.4×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.3× FY 2025
Debt / Equity -0.7×
FY 2016: -0.1×FY 2017: -0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 1.4×FY 2021: 1.3×FY 2022: 3.5×FY 2023: -9.2×FY 2024: -0.7×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
Net Debt / EBITDA -3.6×
FY 2016: -0.0×FY 2017: -0.1×FY 2018: 0.2×FY 2019: -0.0×FY 2020: -0.2×FY 2021: -0.7×FY 2022: -0.7×FY 2023: -1.6×FY 2024: -1.1×FY 2025: -3.6×
FY 2016 5y median -1.1× FY 2025
Interest Coverage -1.0×
FY 2016: -7.3×FY 2017: -2.6×FY 2018: -13.0×FY 2019: -670×FY 2020: -8.1×FY 2021: -4.9×FY 2022: -15.7×FY 2023: -3.0×FY 2024: -2.7×FY 2025: -1.0×
FY 2016 5y median -3.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31